Concepedia
Statistics
Publications
27
Citations
1.5K
H-Index
16
Active since
2011
Affiliations
Dana-Farber Cancer Institute(Current)
University of Chicago
Harvard University
Massachusetts General Hospital
Center for Practical Bioethics
Andrew Hantel is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pharmacotherapy.
Publications per year
2011–2024
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S. Welch, Allegra A. Petti, Christopher A. Miller et al. · New England Journal of Medicine · 2016 · 784 citations · Full text
Life Sciences, Hematology, Pharmacotherapy +17
Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome
Chadi Nabhan, Sonali M. Smith, Irene Helenowski et al. · British Journal of Haematology · 2011 · 95 citations · Full text
Medicine, Geriatric Medicine, Oncology +16
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Andrew Hantel, Brooke Peterson Gabster, Jason X. Cheng et al. · Journal for ImmunoTherapy of Cancer · 2018 · 67 citations · Full text
Medicine, Hematology, Oncology +17
Validation of a financial toxicity (FT) grading system.
Jonas A. de Souza, Kristen Wroblewski, Ellie Proussaloglou et al. · Journal of Clinical Oncology · 2017 · 61 citations
Pharmacy, Oncology, Cancer Drug Toxicity Management +14
Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care
Andrew Hantel, Thomas Walsh, Jonathan M. Marron et al. · JAMA Network Open · 2024 · 46 citations · Full text
Computing, Oncology, Artificial Intelligence +16
1–5 of 27